Effect of TA-CIN (HPV 16 L2E6E7) booster immunisation in vulval intraepithelial neoplasia patients previously vaccinated with TA-HPV (vaccinia virus encoding HPV 16/18 E6E7)

Vaccine
Emma J DavidsonP L Stern

Abstract

Heterologous prime-boost vaccination schedules employing TA-HPV, a vaccinia virus encoding HPV 16/18 E6 and E7, in combination with TA-CIN, an HPV 16 L2E6E7 fusion protein, may offer advantages over the use of either agent alone for the immunotherapy of human papillomavirus (HPV) type 16-associated vulval intraepithelial neoplasia (VIN). In the present study, 10 women with HPV 16-positive high grade VIN, previously primed with TA-HPV, received three booster immunisations with TA-CIN. All but one demonstrated HPV 16-specific proliferative T-cell and/or serological responses following vaccination. Three patients additionally showed lesion shrinkage or symptom relief, but no direct correlation between clinical and immunological responses was seen.

References

Nov 1, 1989·British Journal of Obstetrics and Gynaecology·M I ShafiT P Rollason
Nov 1, 1984·Journal of Clinical Pathology·C H BuckleyH Fox
Oct 8, 1999·Immunity·E Gilboa
Nov 24, 1999·Immunological Reviews·J SchneiderA V Hill
Oct 9, 2002·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·O M McNallyR M Rome
Oct 9, 2002·Journal of Virological Methods·Peter SehrMichael Pawlita
Jun 28, 2003·Viral Immunology·Gretchen L EibenW Martin Kast

❮ Previous
Next ❯

Citations

Feb 18, 2014·Current Obstetrics and Gynecology Reports·Jayne KnoffT-C Wu
Apr 20, 2012·Immunotherapy·Hideyuki NakashimaRaj K Puri
Dec 21, 2010·Annual Review of Immunology·Ian H FrazerStephen R Mattarollo
Nov 17, 2006·Journal of Virology·Mayumi NakagawaAnna-Barbara Moscicki
Mar 25, 2008·Therapeutics and Clinical Risk Management·Ursula WintersPeter Stern
Mar 5, 2010·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Jun-Han SuT-C Wu
Nov 12, 2010·Journal of Translational Medicine·Hideyuki NakashimaRaj K Puri
Apr 16, 2011·Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology·S DaayanaH C Kitchener
Oct 6, 2005·Journal of Lower Genital Tract Disease·Richard W Todd, David M Luesley
Aug 12, 2005·Current Opinion in Oncology·Anna S Kadish, Mark H Einstein
Apr 9, 2008·Journal of Biomedical Science·Annie A WuSara I Pai
Nov 16, 2005·Clinical Obstetrics and Gynecology·Mario PretiMarc Van Beurden
May 8, 2009·Immunology and Cell Biology·Balasubramanyam KaranamRichard B S Roden
Jun 29, 2006·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·A N FianderH C Kitchener
Sep 6, 2005·Current Opinion in Obstetrics & Gynecology·Jessica A Kahn, David I Bernstein
Jun 14, 2012·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Emma J Crosbie, Henry C Kitchener
May 12, 2007·Expert Review of Anticancer Therapy·Gianna Badaracco, Aldo Venuti
Jan 1, 2014·Vaccines·Hadeel KhalloufAngelika B Riemer
Nov 17, 2015·Expert Review of Anticancer Therapy·Gulden MenderesAlessandro D Santin
Mar 21, 2008·Expert Opinion on Biological Therapy·Chien-Fu HungT-C Wu
Nov 21, 2012·Expert Opinion on Emerging Drugs·Barbara MaT-C Wu
Aug 27, 2005·Expert Opinion on Biological Therapy·George CoukosT-C Wu
Jul 23, 2004·Expert Opinion on Investigational Drugs·Peter L Stern
Feb 3, 2016·Human Vaccines & Immunotherapeutics·Joseph G SkeateW Martin Kast
Feb 25, 2014·Clinics in Dermatology·Lis Ribeiro-Müller, Martin Müller
May 21, 2009·Experimental and Molecular Pathology·Kenneth E PalmerShin-je Ghim
Apr 15, 2008·Critical Reviews in Oncology/hematology·H P van de NieuwenhofJ A de Hullu
Feb 24, 2016·Expert Review of Vaccines·Andrew YangChien-Fu Hung
Jun 14, 2008·Gynecologic Oncology·Warner K Huh, Richard B S Roden
Jun 10, 2006·Hematology/oncology Clinics of North America·Andrew EisenbergerHoward L Kaufman
Feb 24, 2016·Expert Review of Vaccines·Rosie T JiangRichard B S Roden
Mar 28, 2008·Immunological Reviews·Chien-Fu HungRichard Roden
Sep 10, 2005·Best Practice & Research. Clinical Obstetrics & Gynaecology·A-L WilliamsonE P Rybicki
Aug 12, 2014·Best Practice & Research. Clinical Obstetrics & Gynaecology·Mario PretiLeonardo Micheletti
Jul 9, 2016·Human Vaccines & Immunotherapeutics·Nicolas Çuburu, John T Schiller
Oct 3, 2009·The Lancet Oncology·Cornelia L Trimble, Ian H Frazer
Sep 10, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert L Ferris
Jan 1, 2011·Cancers·Anne-Sophie BergotDeepak Mittal

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Aphasia

Aphasia affects the ability to process language, including formulation and comprehension of language and speech, as well as the ability to read or write. Here is the latest research on aphasia.